Prime Medicine (PRME)

Prime Medicine (PRME) stock research: performance, analysts' price targets, earnings, revenue and margins, technicals and insider trades.

• PRME last traded at $4.41, -6.57% on the day.
• Prime Medicine: P/E -4.0, revenue $4.07M over the last four quarters.
• Over the past year PRME returned 1.38%; year to date 27.09%.

Updated 2026-11-02 20:36 UTC